Exchange: ASX Industry: Health Care Equipment & Services
1.38% $25.80
America/New_York / 3 mai 2024 @ 02:10
FUNDAMENTALS | |
---|---|
MarketCap: | 15 067 mill |
EPS: | 0.410 |
P/E: | 62.93 |
Earnings Date: | May 28, 2024 |
SharesOutstanding: | 583.98 mill |
Avg Daily Volume: | 0.304 mill |
RATING 2024-05-03 |
---|
A+ |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Buy | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/21 | 3/21 | 1/22 | 3/22 | 1/23 | 3/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
Asset | n/a | n/a | n/a | n/a | n/a | n/a |
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
50.04x |
Company: PE 62.93 | sector: PE 1.258 |
PE RATIO: COMPANY / INDUSTRY |
---|
1.16x |
Company: PE 62.93 | industry: PE 54.21 |
DISCOUNTED CASH FLOW VALUE |
---|
$9.17 (-64.47%) $-16.63 |
Date: 2024-05-03 |
Expected Trading Range (DAY) |
---|
$ 25.17 - 26.43 ( +/- 2.44%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $25.80 (1.38% ) |
Volume | 0.193 mill |
Avg. Vol. | 0.304 mill |
% of Avg. Vol | 63.55 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.